GB202104427D0 - Therapy - Google Patents

Therapy

Info

Publication number
GB202104427D0
GB202104427D0 GBGB2104427.6A GB202104427A GB202104427D0 GB 202104427 D0 GB202104427 D0 GB 202104427D0 GB 202104427 A GB202104427 A GB 202104427A GB 202104427 D0 GB202104427 D0 GB 202104427D0
Authority
GB
United Kingdom
Prior art keywords
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2104427.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immodulon Therapeutics Ltd
Original Assignee
Immodulon Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immodulon Therapeutics Ltd filed Critical Immodulon Therapeutics Ltd
Priority to GBGB2104427.6A priority Critical patent/GB202104427D0/en
Publication of GB202104427D0 publication Critical patent/GB202104427D0/en
Priority to PCT/GB2021/052881 priority patent/WO2022096896A1/en
Priority to CN202180089621.XA priority patent/CN117460526A/en
Priority to EP21814842.7A priority patent/EP4240383A1/en
Priority to JP2023527652A priority patent/JP2023552674A/en
Priority to US18/252,048 priority patent/US20230405114A1/en
Ceased legal-status Critical Current

Links

GBGB2104427.6A 2020-11-06 2021-03-29 Therapy Ceased GB202104427D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB2104427.6A GB202104427D0 (en) 2021-03-29 2021-03-29 Therapy
PCT/GB2021/052881 WO2022096896A1 (en) 2020-11-06 2021-11-05 Mycobacterial immunotherapy for treating cancer
CN202180089621.XA CN117460526A (en) 2020-11-06 2021-11-05 Mycobacterium immunotherapy for the treatment of cancer
EP21814842.7A EP4240383A1 (en) 2020-11-06 2021-11-05 Mycobacterial immunotherapy for treating cancer
JP2023527652A JP2023552674A (en) 2020-11-06 2021-11-05 Mycobacterial immunotherapy for cancer treatment
US18/252,048 US20230405114A1 (en) 2020-11-06 2021-11-05 Mycobacterial immunotherapy for treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2104427.6A GB202104427D0 (en) 2021-03-29 2021-03-29 Therapy

Publications (1)

Publication Number Publication Date
GB202104427D0 true GB202104427D0 (en) 2021-05-12

Family

ID=75783783

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2104427.6A Ceased GB202104427D0 (en) 2020-11-06 2021-03-29 Therapy

Country Status (2)

Country Link
CN (1) CN117460526A (en)
GB (1) GB202104427D0 (en)

Also Published As

Publication number Publication date
CN117460526A (en) 2024-01-26

Similar Documents

Publication Publication Date Title
GB202001980D0 (en) Therapeutic mentods
GB202006960D0 (en) Therapeutic
GB202108303D0 (en) Therapy
GB202111288D0 (en) Combination therapy
GB202004189D0 (en) Combination therapy
GB202117706D0 (en) Therapy
GB202111035D0 (en) Therapy
GB202109893D0 (en) PeptiBAC therapy
GB202104427D0 (en) Therapy
GB202103164D0 (en) Therapy
GB202102211D0 (en) PeptiBAC therapy
GB202019218D0 (en) Therapy
GB202017554D0 (en) Therapy
GB202017598D0 (en) Therapy
GB202015778D0 (en) Therapy
GB202015780D0 (en) Therapy
GB202013834D0 (en) PeptiVAX therapy
GB202013824D0 (en) PeptiBAC therapy
GB202009039D0 (en) Therapy
GB202008031D0 (en) Therapy
GB202004629D0 (en) Therapy
GB202004013D0 (en) Therapy
GB202002639D0 (en) Therapy
GB202001905D0 (en) Therapy
IL304223A (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)